BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 36645189)

  • 1. Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort.
    Ishiyama Y; Shimbo M; Iizuka J; Deshpande G; Tanabe K; Hattori K
    PLoS One; 2020; 15(12):e0244149. PubMed ID: 33351846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular testing of prostate cancer: timing, methods and consequences].
    von Amsberg G; Paulsen FO
    Aktuelle Urol; 2024 Apr; 55(2):123-133. PubMed ID: 38537659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypercalcaemia in metastatic prostate cancer with biallelic BRCA2 mutations and lytic bone lesions.
    Lazzari L; Ledet E; Hawkins M; Sartor O
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37562861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis reveals the
    Hsiao TH; Chiu YC; Shao YJ
    Transl Cancer Res; 2019 Aug; 8(4):1279-1288. PubMed ID: 35116870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic DNA copy number alterations and their potential clinical utility for predicting lethal prostate cancer.
    Liu W; Wang L; Xu J
    Asian J Androl; 2013 Sep; 15(5):586-7. PubMed ID: 23817503
    [No Abstract]   [Full Text] [Related]  

  • 6. Genome-wide integrative analysis revealed a correlation between lengths of copy number segments and corresponding gene expression profile.
    Miyaguchi K; Fukuoka Y; Mizushima H; Yasen M; Nemoto S; Ishikawa T; Uetake H; Tanaka S; Sugihara K; Arii S; Tanaka H
    Bioinformation; 2011; 7(6):280-4. PubMed ID: 22355221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Gene Next-Generation Sequencing Panel for Analysis of
    Maloberti T; De Leo A; Coluccelli S; Sanza V; Gruppioni E; Altimari A; Zagnoni S; Giunchi F; Vasuri F; Fiorentino M; Mollica V; Ferrari S; Miccoli S; Visani M; Turchetti D; Massari F; Tallini G; de Biase D
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of BRCA and ctDNA as Prostate Cancer Biomarkers: A Meta-Analysis.
    Domrazek K; Pawłowski K; Jurka P
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
    Golan T; Raitses-Gurevich M; Kelley RK; Bocobo AG; Borgida A; Shroff RT; Holter S; Gallinger S; Ahn DH; Aderka D; Apurva J; Bekaii-Saab T; Friedman E; Javle M
    Oncologist; 2017 Jul; 22(7):804-810. PubMed ID: 28487467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.
    Nukaya T; Sumitomo M; Sugihara E; Takeda M; Nohara S; Tanishima S; Takenaka M; Zennami K; Takahara K; Shiroki R; Saya H
    Cancer Med; 2023 Apr; 12(7):8154-8165. PubMed ID: 36645189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.
    Kim SH; Park WS; Yun SI; Joo J; Joung JY; Seo HK; Chung J; Lee GK; Lee KH
    Histopathology; 2016 Apr; 68(5):673-9. PubMed ID: 26272590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.
    Petrovics G; Price DK; Lou H; Chen Y; Garland L; Bass S; Jones K; Kohaar I; Ali A; Ravindranath L; Young D; Cullen J; Dorsey TH; Sesterhenn IA; Brassell SA; Rosner IL; Ross D; Dahut W; Ambs S; Figg WD; Srivastava S; Dean M
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):406-410. PubMed ID: 30542053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline BRCA mutation in male carriers-ripe for precision oncology?
    Leão RRN; Price AJ; James Hamilton R
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):48-56. PubMed ID: 29242595
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.